Emergex Vaccines Stock
Pioneering a new approach to vaccine development and manufacturing using cutting-edge technologies to produce novel synthetic vaccines.
Sign up today and learn more about Emergex Vaccines Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Emergex Vaccines Stock
Emergex Vaccines offer affordable, practical and effective vaccines on-demand, which are suited to low resource environments, disproportionately affected by pandemics. These vaccines will be used to create a clinical grade international vaccine repository that will act as a first line of defence in the case of existing and newly emerging infectious disease outbreaks.
Investors
Vickers Venture Partners
Funding History
| May 2018 | $979K |
|---|---|
| January 2020 | $11.0M |
| February 2022 | $491K |
Management
Founder and CEO
Thomas Rademacher
Founder, Executive Director, Chief Operating Officer
Storme Moore-Thornicroft
Press
linkedin - Apr, 6 2024
Emergex Vaccines on LinkedIn: #emergex #id #rnavirus #tcellglobenewswire - Mar, 2 2024
Emergex Announces R&D Collaboration with DEKA Research & Development Corp. for Assessment of Emergex's ...thebusinessmagazine - Mar, 2 2024
Emergex Vaccines expands at Milton Parkfinance - Jan, 20 2024
Emergex Announces Authorisation from Philippines FDA to ...medgadget - Dec, 24 2023
Hand, Foot, And Mouth Disease Treatment Market to Witness ...EquityZen Recognized As:
